D, R., L, B., & V, R. (2024). A marginalized two-part joint model for a longitudinal biomarker and a terminal event with application to advanced head and neck cancers. Pharmaceutical statistics, 23(1), 60. https://doi.org/10.1002/pst.2338
Chicago Style (17th ed.) CitationD, Rustand, Briollais L, and Rondeau V. "A Marginalized Two-part Joint Model for a Longitudinal Biomarker and a Terminal Event with Application to Advanced Head and Neck Cancers." Pharmaceutical Statistics 23, no. 1 (2024): 60. https://doi.org/10.1002/pst.2338.
MLA (9th ed.) CitationD, Rustand, et al. "A Marginalized Two-part Joint Model for a Longitudinal Biomarker and a Terminal Event with Application to Advanced Head and Neck Cancers." Pharmaceutical Statistics, vol. 23, no. 1, 2024, p. 60, https://doi.org/10.1002/pst.2338.